Salmones Camanchaca S.A. (SNSE:SALMOCAM)
Chile · Delayed Price · Currency is CLP | Market Cap | 389.24B +86.7% |
| Revenue (ttm) | 347.43B -4.6% |
| Net Income | 22.99B +83.4% |
| EPS | 309.91 +83.4% |
| Shares Out | 74.20M |
| PE Ratio | 16.93 |
| Forward PE | 9.52 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4 |
| Average Volume | 1,742 |
| Open | n/a |
| Previous Close | 5,246.20 |
| Day's Range | n/a |
| 52-Week Range | 2,762.90 - 5,250.30 |
| Beta | 0.32 |
| RSI | 76.17 |
| Earnings Date | Apr 14, 2026 |
About Salmones Camanchaca
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic salmon, including whole/HG, steak, servings, and other products; and whole/HG coho, coho steak, and coho portions. It also exports its products. The company was founded in 1987 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. operates as a subsidiary of Camanchaca S.A. [Read more]
Financial Performance
In 2025, Salmones Camanchaca's revenue was $385.70 million, a decrease of -4.65% compared to the previous year's $404.50 million. Earnings were $25.53 million, an increase of 83.41%.
Financial numbers in USD Financial StatementsNews
Salmones Camanchaca Earnings Call Transcript: Q2 2025
Operational revenue dropped 26% year-over-year in Q2 2025 due to planned coho harvest reductions, but cost efficiencies and higher prices for both species drove a 50%+ increase in adjusted EBITDA. Net debt fell 23%, and the company expects accelerated harvests and price recovery in 2026.
Salmones Camanchaca Earnings Call Transcript: Q1 2025
First quarter 2025 saw a 27% increase in harvest and a fourfold rise in EBITDA, driven by cost reductions and improved biological results, despite an 11% revenue drop from planned coho reductions. Net debt fell over 30%, and the company projects strong growth and lower financial expenses ahead.
Salmones Camanchaca Earnings Call Transcript: Q4 2024
Q4 2024 saw a 27% revenue increase and strong EBITDA growth, driven by higher Atlantic and Coho volumes, cost reductions, and improved biological results. Net debt fell, and guidance points to further harvest growth in 2025–2026, with stable market prices expected.
Salmones Camanchaca Earnings Call Transcript: Q3 2024
Q3 2024 saw EBITDA triple year-over-year to $9.2 million, driven by lower production costs and strong biological performance, despite a 12% revenue drop. Net profit reached $4.1 million, and harvest guidance for 2024 and 2025 remains on track.
Salmones Camanchaca Earnings Call Transcript: Q2 2024
Q2 2024 saw a 50% revenue increase year-over-year, driven by higher Atlantic salmon harvests, despite significant price declines. Cost reductions, strong biological performance, and non-recurrent gains supported margins, while market and currency headwinds persisted.